Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)
SKU ID : 99ST-18266639 | Publishing Date : 12-May-2021 | No. of pages : 107
Detailed TOC of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)
TABLE OF CONTENTS1 INDUSTRY OVERVIEW
1.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry
1.1.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Overview
1.1.2 Terminology Definition in the Report
1.1.2.1 Capacity
1.1.2.2 Sales Volume
1.1.2.3 Sales Revenue
1.1.2.4 Ex-factory Price & Sales Price
1.1.2.5 Cost
1.1.2.6 Gross Margin
1.2 Products & Services Overview Scope
1.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug in the Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview
2 UPSTREAM & MANUFACTURING
2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity Overview
2.5 Production Distribution by Geography
2.5.1 Production in Major Regions / Countries
2.5.2 Trade Flow Overview
3 PRODUCT SEGMENT
3.1 Product Segmentation Market (2017 to 2021E)
3.1.1 SGD-2083 Market
3.1.2 Crizanlizumab Market
3.1.3 PF-04447943 Market
3.1.4 NVX-508 Market
3.1.5 Others Market
3.2 Market Status
4 APPLICATION / END-USE SEGMENT
4.1 Application Segmentation Market (2016 to 2021E)
4.1.1 Clinic Market
4.1.2 Hospital Market
4.1.3 Others Market
4.2 Market Status
5 NORTH AMERICA
5.1 North America Market Growth
5.2 North America Market by Countries
5.3 Major Countries Market Growth
5.3.1 United States Market Size and Growth (2016-2021E)
5.3.2 Canada Market Size and Growth (2016-2021E)
5.3.3 Mexico Market Size and Growth (2016-2021E)
6 EUROPE
6.1 Europe Market Growth
6.2 Europe Market by Countries
6.3 Major Countries Market Growth
6.3.1 Germany Market Size and Growth (2016-2021E)
6.3.2 UK Market Size and Growth (2016-2021E)
6.3.3 France Market Size and Growth (2016-2021E)
6.3.4 Russia Market Size and Growth (2016-2021E)
6.3.5 Italy Market Size and Growth (2016-2021E)
6.3.6 Rest of Europe Market Size and Growth (2016-2021E)
7 ASIA-PACIFIC
7.1 ASIA-PACIFIC Market Growth
7.2 ASIA-PACIFIC Market by Countries
7.3 Major Countries Market Growth
7.3.1 China Market Size and Growth (2016-2021E)
7.3.2 India Market Size and Growth (2016-2021E)
7.3.3 Japan Market Size and Growth (2016-2021E)
7.3.4 South Korea Market Size and Growth (2016-2021E)
7.3.5 Southeast Asia Market Size and Growth (2016-2021E)
7.3.6 Australia Market Size and Growth (2016-2021E)
7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E)
8 SOUTH AMERICA
8.1 South America Market Growth
8.2 South America Market by Countries
8.3 Major Countries Market Growth
8.3.1 Brazil Market Size and Growth (2016-2021E)
8.3.2 Argentina Market Size and Growth (2016-2021E)
8.3.3 Rest of South America Market Size and Growth (2016-2021E)
9 MIDDLE EAST & AFRICA
9.1 Middle East and Africa Market Growth
9.2 Middle East and Africa Market by Countries
9.3 Major Countries Market Growth
9.3.1 GCC Market Size and Growth (2016-2021E)
9.3.2 North Africa Market Size and Growth (2016-2021E)
9.3.3 South Africa Market Size and Growth (2016-2021E)
9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E)
10 MARKET FORECAST
10.1 Global Market Forecast Overview
10.2 Global Market Forecast by Type
10.3 Global Market Forecast by Application / End-Use
10.4 Global Market Forecast by Region
11 COMPETITION OF MAJOR PLAYERS
11.1 AstraZeneca Plc (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.1.1 AstraZeneca Plc Profile
11.1.2 AstraZeneca Plc Products & Services Overview
11.1.3 AstraZeneca Plc Main Business
11.1.4 AstraZeneca Plc Business Operation
11.2 Bristol-Myers Squibb Company (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.2.1 Bristol-Myers Squibb Company Profile
11.2.2 Bristol-Myers Squibb Company Products & Services
11.2.3 Bristol-Myers Squibb Company Main Business
11.2.4 Bristol-Myers Squibb Company Business Operation
11.3 Gilead Sciences Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.3.1 Gilead Sciences Inc Profile
11.3.2 Gilead Sciences Inc Products & Services
11.3.3 Gilead Sciences Inc Main Business
11.3.4 Gilead Sciences Inc Business Operation
11.4 Modus Therapeutics Holding AB (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.4.1 Modus Therapeutics Holding AB Profile
11.4.2 Modus Therapeutics Holding AB Products & Services
11.4.3 Modus Therapeutics Holding AB Main Business
11.4.4 Modus Therapeutics Holding AB Business Operation
11.5 Novartis AG (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.5.1 Novartis AG Profile
11.5.2 Novartis AG Products & Services
11.5.3 Novartis AG Main Business
11.5.4 Novartis AG Business Operation
11.6 NuvOx Pharma LLC (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.6.1 NuvOx Pharma LLC Profile
11.6.2 NuvOx Pharma LLC Products & Services
11.6.3 NuvOx Pharma LLC Main Business
11.6.4 NuvOx Pharma LLC Business Operation
11.7 Pfizer Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.7.1 Pfizer Inc Profile
11.7.2 Pfizer Inc Products & Services
11.7.3 Pfizer Inc Main Business
11.7.4 Pfizer Inc Business Operation
11.8 Seattle Genetics Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.8.1 Seattle Genetics Inc Profile
11.8.2 Seattle Genetics Inc Products & Services
11.8.3 Seattle Genetics Inc Main Business
11.8.4 Seattle Genetics Inc Business Operation
12 COMPANY COMPETITION
12.1 Global Sales by Company
12.1.1 Global Sales by Company
12.1.2 Global Sales Share by Company
12.2 Price & Gross Margin
12.3 Landscape of Major Companies in the Market
12.3.1 Major Companies Product Type List
12.3.1 Manufacturing Regions and Headquarters of Major Companies
12.3.1 Mergers & Acquisitions
12.4 Competitive Environment for New Entrants
12.4.1 Michael Porter's Five Forces Model
12.4.2 SWOT
13 ENVIRONMENT OVERVIEW
13.1 Impact of COVID-19
13.2 Geopolitics Overview
13.3 Economic Overview of Major Countries
14 RESEARCH CONCLUSION
List of Figures, Tables and Charts Available in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)
LIST OF TABLETABLE ~ Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Dynamics & Regulations List
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E
TABLE ~ SGD-2083 Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ SGD-2083 Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Crizanlizumab Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Crizanlizumab Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ PF-04447943 Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ PF-04447943 Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ NVX-508 Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ NVX-508 Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in Volume
TABLE ~ Clinic Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Clinic Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Hospital Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Hospital Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in Volume
TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million
TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume
TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume
TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million
TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume
TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume
TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million
TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume
TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume
TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million
TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume
TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume
TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million
TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume
TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume
TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Type 2022F-2026F, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Type 2022F-2026F, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Type 2022F-2026F, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Type 2022F-2026F, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Application / End-Use 2022F-2026F, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Application / End-Use 2022F-2026F, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Region 2022F-2026F, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Region 2022F-2026F, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Region 2022F-2026F, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Region 2022F-2026F, in Volume
TABLE ~ AstraZeneca Plc Overview List
TABLE ~ Products & Services List of AstraZeneca Plc
TABLE ~ Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Bristol-Myers Squibb Company Overview List
TABLE ~ Products & Services List of Bristol-Myers Squibb Company
TABLE ~ Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Gilead Sciences Inc Overview List
TABLE ~ Products & Services List of Gilead Sciences Inc
TABLE ~ Business Operation of Gilead Sciences Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Modus Therapeutics Holding AB Overview List
TABLE ~ Products & Services List of Modus Therapeutics Holding AB
TABLE ~ Business Operation of Modus Therapeutics Holding AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Novartis AG Overview List
TABLE ~ Products & Services List of Novartis AG
TABLE ~ Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ NuvOx Pharma LLC Overview List
TABLE ~ Products & Services List of NuvOx Pharma LLC
TABLE ~ Business Operation of NuvOx Pharma LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Pfizer Inc Overview List
TABLE ~ Products & Services List of Pfizer Inc
TABLE ~ Business Operation of Pfizer Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Seattle Genetics Inc Overview List
TABLE ~ Products & Services List of Seattle Genetics Inc
TABLE ~ Business Operation of Seattle Genetics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Company 2016-2021E, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Company 2016-2021E, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Company 2016-2021E, in USD Million
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Company 2016-2021E, in Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Price by Company 2016-2021E, in USD/Volume
TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Gross Margin by Company 2016-2021E
TABLE ~ Major Companies Product Type List
TABLE ~ Major Companies Product Type List
TABLE ~ Mergers & Acquisitions in the Market